These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 577091)

  • 21. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis.
    Stahl WL; Sumi SM; Swanson PD
    J Neurochem; 1971 Mar; 18(3):403-13. PubMed ID: 5559251
    [No Abstract]   [Full Text] [Related]  

  • 23. Vogt's retro-iridian pigment lines. Light microscopical and ultrastructural study of a case.
    Larsen FE; Hvidberg J
    Acta Ophthalmol (Copenh); 1976 Oct; 54(5):641-53. PubMed ID: 990015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.
    Peynet J; Laurent A; De Liege P; Lecoz P; Gambert P; Legrand A; Mikol J; Warnet A
    Neurology; 1991 Mar; 41(3):434-6. PubMed ID: 2006015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial enzyme deficiency in cerebrotendinous xanthomatosis.
    Dotti MT; Manneschi L; Federico A
    J Neurol Sci; 1995 Apr; 129(2):106-8. PubMed ID: 7608723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in The Netherlands.
    Waterreus RJ; Koopman BJ; Wolthers BG; Oosterhuis HJ
    Clin Neurol Neurosurg; 1987; 89(3):169-75. PubMed ID: 3665290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De- and remyelination and onion bulb in cerebrotendinous xanthomatosis.
    Ohnishi A; Yamashita Y; Goto I; Kuroiwa Y; Murakami S; Ikeda M
    Acta Neuropathol; 1979 Jan; 45(1):43-5. PubMed ID: 760364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrotendinous xanthomatosis. Clinical and pathological studies.
    Schimschock JR; Alvord EC; Swanson PD
    Arch Neurol; 1968 Jun; 18(6):688-98. PubMed ID: 5652996
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebrotendinous xanthomatosis.
    Truswell AS; Pfister PJ
    Br Med J; 1972 Feb; 1(5796):353-4. PubMed ID: 5008664
    [No Abstract]   [Full Text] [Related]  

  • 30. [Parkinsonism associated with cerebrotendinous xanthomatosis].
    Shibata N; Moroo I; Hayashi M
    Rinsho Shinkeigaku; 1990 Sep; 30(9):978-84. PubMed ID: 2265509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced C27-steroid 26-hydroxylase activity in heterozygotes for cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Kvittingen EA; East C; Grundy S; Skrede S
    Scand J Clin Lab Invest; 1988 Sep; 48(5):425-9. PubMed ID: 3206189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report.
    Siebner HR; Berndt S; Conrad B
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):582-5. PubMed ID: 8778269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Berginer V
    Dev Neurosci; 1991; 13(4-5):363-70. PubMed ID: 1817043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electron microscopic studies on the lens of exfoliation syndrome. II. On the non-exfoliated fellow eye].
    Ueno H; Noda K; Tamai A; Kishi S; Kitagawa K; Takahashi T; Watanabe M; Ogura C
    Nippon Ganka Gakkai Zasshi; 1987 Nov; 91(11):1036-43. PubMed ID: 3445831
    [No Abstract]   [Full Text] [Related]  

  • 35. [Magnetic resonance of the brain and Achilles tendon in cerebrotendinous xanthomatosis].
    Pardo J; Prieto JM; Rodríguez JR; Vadillo J; Dapena MD; Noya M
    Neurologia; 1993 Oct; 8(8):268-70. PubMed ID: 8240840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.
    Canelas HM; Quintão EC; Scaff M; Vasconcelos KS; Brotto MW
    Acta Neurol Scand; 1983 May; 67(5):305-11. PubMed ID: 6410671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maturation of fiber membranes in the human eye lens. Ultrastructural and Raman microspectroscopic observations.
    Vrensen GF; Duindam HJ
    Ophthalmic Res; 1995; 27 Suppl 1():78-85. PubMed ID: 8577466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The ultrastructure of human and mouse cataractous lens epithelial cell apoptosis].
    Chen F; Chen C; Song X
    Zhonghua Yan Ke Za Zhi; 2000 Mar; 36(2):107-8, 10. PubMed ID: 11853595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrotendinous xanthomatosis.
    Pastershank SP; Yip S; Sodhi HS
    J Can Assoc Radiol; 1974 Dec; 25(4):282-6. PubMed ID: 4443363
    [No Abstract]   [Full Text] [Related]  

  • 40. Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis.
    Cruysberg JR; Wevers RA; Tolboom JJ
    Am J Ophthalmol; 1991 Nov; 112(5):606-7. PubMed ID: 1951610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.